FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bio-Techne's Free Cash Flow for the
three
months ended in Dec. 2023 was $68 Mil. Bio-Techne's Revenue for the
three
months ended in Dec. 2023 was $273 Mil. Therefore, Bio-Techne's FCF Margin % for the quarter that ended in Dec. 2023 was 25.04%.
As of today, Bio-Techne's current FCF Yield % is 2.25%.
The historical rank and industry rank for Bio-Techne's FCF Margin % or its related term are showing as below:
TECH'
s FCF Margin % Range Over the Past 10 Years
Min: 19.02 Med: 24.3 Max: 34.36
Current: 19.68
During the past 13 years, the highest FCF Margin % of Bio-Techne was 34.36%. The lowest was 19.02%. And the median was 24.30%.
TECH's FCF Margin % is ranked better than 91.36% of 1030
companies
in the Biotechnology industry
Industry Median: -148.935
vs TECH: 19.68
Bio-Techne FCF Margin % Historical Data
The historical data trend for Bio-Techne's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bio-Techne's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne FCF Margin % Distribution
For the Biotechnology industry and Healthcare sector, Bio-Techne's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bio-Techne's FCF Margin % falls into.
Bio-Techne FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Bio-Techne's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne FCF Margin % Related Terms
Thank you for viewing the detailed overview of Bio-Techne's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your 